Ben Laufer
Ben Laufer

Principal Scientist II

About

Ben Laufer is a computational biologist who researches gene expression and neuroscience. He is part of the Neuroinformatics Group in the Department of Computational Biology & Medicine at Genentech.

Interests
  • Bioinformatics
  • Gene Regulation
  • Neuroscience
Education
  • Postdoctoral Fellowship

    University of California Davis, USA

  • PhD in Cellular & Molecular Biology

    Western University, Canada

  • BSc (Hons) in Genetics

    Western University, Canada

Recent Publications
(2025). Multiplex screening of transferrin receptor-targeted lipid nanoparticles for systemic brain delivery using DNA barcodes. Cell Biomaterials.
DOI
(2025). Predictive in vitro profiling of LNP-induced innate immune response using an iPSC-derived monocyte model. bioRxiv.
DOI
(2025). Integrated Cross-Disease Atlas of Human And Mouse Astrocytes Reveals Heterogeneity and Conservation of Astrocyte Subtypes in Neurodegeneration. bioRxiv.
DOI
(2023). TMEM106B reduction does not rescue GRN deficiency in iPSC-derived human microglia and mouse models. iScience.
DOI
(2023). Lipid nanoparticle delivery limits antisense oligonucleotide activity and cellular distribution in the brain after intracerebroventricular injection. Molecular Therapy — Nucleic Acids.
DOI